BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 14640682)

  • 1. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
    Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
    Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of conserved glycine residues within the membrane-spanning domain of human immunodeficiency virus type 1 gp41 can inhibit membrane fusion and incorporation of Env onto virions.
    Miyauchi K; Curran R; Matthews E; Komano J; Hoshino T; Engelman DM; Matsuda Z
    Jpn J Infect Dis; 2006 Apr; 59(2):77-84. PubMed ID: 16632906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion.
    Miyauchi K; Komano J; Yokomaku Y; Sugiura W; Yamamoto N; Matsuda Z
    J Virol; 2005 Apr; 79(8):4720-9. PubMed ID: 15795258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120.
    Day JR; Van Damme N; Guatelli JC
    Virology; 2006 Oct; 354(2):316-27. PubMed ID: 16905171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41.
    Gallo SA; Clore GM; Louis JM; Bewley CA; Blumenthal R
    Biochemistry; 2004 Jun; 43(25):8230-3. PubMed ID: 15209519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
    Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
    J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
    Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
    Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
    Chen SS; Lee SF; Wang CT
    J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altered receptor activation of gp120.
    Desmezieres E; Gupta N; Vassell R; He Y; Peden K; Sirota L; Yang Z; Wingfield P; Weiss CD
    J Virol; 2005 Apr; 79(8):4774-81. PubMed ID: 15795263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structural biology of type I viral membrane fusion.
    Colman PM; Lawrence MC
    Nat Rev Mol Cell Biol; 2003 Apr; 4(4):309-19. PubMed ID: 12671653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.
    Wyss S; Dimitrov AS; Baribaud F; Edwards TG; Blumenthal R; Hoxie JA
    J Virol; 2005 Oct; 79(19):12231-41. PubMed ID: 16160149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminal 12 residue long peptide of HIV gp41 is the minimal peptide sufficient to induce significant T-cell-like membrane destabilization in vitro.
    Charloteaux B; Lorin A; Crowet JM; Stroobant V; Lins L; Thomas A; Brasseur R
    J Mol Biol; 2006 Jun; 359(3):597-609. PubMed ID: 16677669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41.
    Salzwedel K; Berger EA
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12794-9. PubMed ID: 11050186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of fusion peptides from HIV gp41 with membranes: a time-resolved membrane binding, lipid mixing, and structural study.
    Buzón V; Padrós E; Cladera J
    Biochemistry; 2005 Oct; 44(40):13354-64. PubMed ID: 16201760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    Keller PW; Morrison O; Vassell R; Weiss CD
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E; Hummer G; Bewley CA; Clore GM
    J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational stability and membrane interaction of the full-length ectodomain of HIV-1 gp41: implication for mode of action.
    Lev N; Fridmann-Sirkis Y; Blank L; Bitler A; Epand RF; Epand RM; Shai Y
    Biochemistry; 2009 Apr; 48(14):3166-75. PubMed ID: 19206186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.